Whitehawk Therapeutics

Whitehawk Therapeutics

Yahoo Finance • 17 days ago

Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

Former Incyte Executive Brings Extensive Oncology, Corporate Strategy, Business Development and Medical Affairs Experience MORRISTOWN, N.J., Sept. 10, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage onco... Full story

Yahoo Finance • 4 months ago

Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy

What happened According to an SEC filing dated May 15, 2026, Acuta Capital Partners, LLC initiated a new position in Erasca(NASDAQ:ERAS) during the first quarter. The fund acquired 354,575 shares, with an estimated transaction value of $4... Full story

Yahoo Finance • 5 months ago

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Quantum Cyber (NASDAQ:QUCY) shares rose 163.0% to $0.85 during Wednesday's regular session. The market value of their outstanding shares is at $4.0 million. Whitehawk Therapeutics (NASDAQ:WHWK) stock moved upwards by 29.59% to $5.... Full story

Yahoo Finance • 5 months ago

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers Quantum Cyber (NASDAQ:QUCY) shares increased by 55.0% to $0.5 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.0 million. SELLAS Life Sciences Gr (NASDAQ:SLS) shares increased by 21.26%... Full story

Yahoo Finance • 11 months ago

Whitehawk Therapeutics GAAP EPS of -$0.26 misses by $0.33

* Whitehawk Therapeutics press release [https://seekingalpha.com/pr/20296637-whitehawk-therapeutics-reports-third-quarter-2025-financial-results-and-recent-highlights] (WHWK [https://seekingalpha.com/symbol/WHWK]): Q3 GAAP EPS of -$0.26 m... Full story

Yahoo Finance • 11 months ago

Tempus partners with Whitehawk Therapeutics to advance cancer research

[Using AI technology helps with genetic code prediction research.] Suriphon Singha/iStock via Getty Images * Tempus AI (NASDAQ:TEM [https://seekingalpha.com/symbol/TEM]) has partnered with Whitehawk Therapeutics (NASDAQ:WHWK [https://se... Full story

Yahoo Finance • last year

US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche

Company Logo The United States Personalized Medicine Market is projected to soar to US$ 307.04 billion by 2033 from US$ 169.56 billion in 2024, experiencing a CAGR of 6.82% from 2025 to 2033. Key growth drivers include advances in next-ge... Full story

Yahoo Finance • last year

Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

MORRISTOWN, N.J., June 19, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments... Full story

Yahoo Finance • last year

Whitehawk Therapeutics reports annual meeting results

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK), a pharmaceutical company with a market capitalization of $94 million, announced the outcomes of its annual stockholders’ meeting held on June 11, 2025. According to InvestingPro analysis, the com... Full story